0001213900-22-009673.txt : 20220228
0001213900-22-009673.hdr.sgml : 20220228
20220228142002
ACCESSION NUMBER: 0001213900-22-009673
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220223
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WOUDENBERG MICHAEL
CENTRAL INDEX KEY: 0001817884
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39685
FILM NUMBER: 22687485
MAIL ADDRESS:
STREET 1: C/O INMED PHARMACEUTICALS INC.
STREET 2: SUITE 310 - 815 HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
4
1
ownership.xml
X0306
4
2022-02-23
0
0001728328
InMed Pharmaceuticals Inc.
INM
0001817884
WOUDENBERG MICHAEL
C/O INMED PHARMACEUTICALS INC.
310-815 WEST HASTINGS ST.
VANCOUVER
A1
V6C1B4
BRITISH COLUMBIA, CANADA
0
1
0
0
See Remarks
Employee Stock Option (Right to Buy)
1.01
2022-02-23
4
A
0
5000
0.00
A
2027-02-22
Common shares
5000
96060
D
The options were granted on 2/23/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
SVP, Chem/Manufacturing/Control
/s/ Bruce Colwill, attorney-in-fact for Mr. Michael Woudenberg
2022-02-28